Distribution of single nucleotide polymorphisms related to paclitaxel and carboplatin toxicity in ovarian cancer patients

被引：0
|
作者：
Cordova, Miguel
Bravo, Maria L.
Arriagada, Isidora
Cumsille, Elisa
Quinones, Luis
Bravo, Erasmo
Correa, Raimundo
Leiva, Juan E.
Paredes, Cesar
Cuello, Mauricio
Ibanez, Carolina
Garrido, Marcelo
Owen, Gareth I.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-5031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5031
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Genome-wide study of carboplatin and paclitaxel disposition in ovarian cancer patients
    Gao, Bo
    Lu, Yi
    Nieuweboer, Annemieke J. M.
    Xu, Hongmei
    Beesley, Jonathan
    Boere, Ingrid
    de Graan, Anne-Joy M.
    de Bruijn, Peter
    Gurney, Howard
    Kennedy, Catherine
    Chiew, Yoke-Eng
    Johnatty, Sharon E.
    Beale, Philip
    Harrison, Michelle
    Luccarini, Craig
    Dunning, Alison M.
    Mathijssen, Ron H. J.
    Harnett, Paul
    Balleine, Rosemary L.
    Chenevix-Trench, Georgia
    MacGregor, Stuart
    deFazio, Anna
    CANCER RESEARCH, 2015, 75
  • [32] Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Martin Pölcher
    Meike Eckhardt
    Christoph Coch
    Matthias Wolfgarten
    Kirsten Kübler
    Gunther Hartmann
    Walther Kuhn
    Christian Rudlowski
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 203 - 207
  • [33] The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer
    Emmanouil V. Dermitzakis
    Vasilios K. Kimiskidis
    George Lazaridis
    Zoi Alexopoulou
    Eleni Timotheadou
    Alexandros Papanikolaou
    Ourania Romanidou
    George Georgiadis
    Konstantine T. Kalogeras
    Iakovos Tsiptsios
    Basil Tarlatzis
    George Fountzilas
    BMC Neurology, 16
  • [34] Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Poelcher, Martin
    Eckhardt, Meike
    Coch, Christoph
    Wolfgarten, Matthias
    Kuebler, Kirsten
    Hartmann, Gunther
    Kuhn, Walther
    Rudlowski, Christian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) : 203 - 207
  • [35] Chemotherapy for ovarian cancer: Beyond paclitaxel plus carboplatin
    Ozols, RF
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (06): : 336 - 338
  • [36] Challenges to the Paclitaxel/Carboplatin Algorithm in Ovarian Cancer Treatment
    Zorn, Kristin K.
    ONCOLOGY-NEW YORK, 2010, 24 (08): : 738 - 740
  • [37] Genomic instability in ovarian cancer: Through the lens of single nucleotide polymorphisms
    Sistla, Harshavardhani Canchi
    Talluri, Srikanth
    Rajagopal, Taruna
    Venkatabalasubramanian, Sivaramakrishna
    Dunna, Nageswara Rao
    CLINICA CHIMICA ACTA, 2025, 565
  • [38] Sequential regimens with paclitaxel, carboplatin, and topotecan in ovarian cancer
    Carmichael, J
    Chan, S
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 97 - 97
  • [39] Paclitaxel and carboplatin loaded pegylated liposomes for ovarian cancer
    Tandel, Hemal T., Jr.
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [40] Weekly Carboplatin and Paclitaxel for Ovarian Cancer: The "Finer Points"
    Muggia, Franco
    ONCOLOGIST, 2021, 26 (01): : 1 - 3
12345